Active	Status	Sponsor type	Region	Phase	Filter
9 Active 1 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Li, Zhihui
NCT04908865: Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)	Active, not recruiting	4	67	RoW	Belimumab, Standard therapy	GlaxoSmithKline	Systemic Lupus Erythematosus	05/24	09/24
NCT05772871: The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children	Recruiting	4	402	RoW	Huaiqihuang granule, Prednisone, Levamisole placebo, Levamisole, Huaiqihuang Granule placebo	Jianhua Zhou, LinkDoc Technology (Beijing) Co. Ltd.	Nephrotic Syndrome in Children	09/25	10/25
NCT05925452: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.	Recruiting	N/A	221	RoW	GenaKumab	Changchun GeneScience Pharmaceutical Co., Ltd.	Active Systemic Juvenile Idiopathic Arthritis	03/28	06/28